德适生物发布医学影像通用大模型，覆盖90%临床场景

Core Insights - The article highlights the launch of iMedImage™, a large-scale medical imaging model developed by Deshi Bio, which is based on 80 million data points and supports 19 modalities, covering over 90% of clinical scenarios [1] - iMedImage™ significantly reduces data dependency and development costs by over 90%, requiring only hundreds of images and a few days for training specialized models compared to traditional methods [1] - Deshi Bio has received the Sullivan Global Medical Imaging Foundation's Innovation Award for iMedImage™ and aims to lower the barriers for AI applications in medical research and clinical settings [1] - During the event, Deshi Bio signed strategic cooperation agreements with Wutongshu, Inspur Group, and ZTE Corporation to advance the research and industrial application of AI in medical imaging [1] Summary by Categories Product Development - iMedImage™ is the largest general medical imaging model globally, trained on 80 million data points [1] - The model supports 19 imaging modalities, including chromosome, CT, and MRI, and covers over 90% of clinical scenarios [1] - The training process is automated and requires minimal data input, significantly reducing the time and resources needed for model development [1] Cost Efficiency - iMedImage™ reduces the data dependency for specialized models to just hundreds of images and training time to a few days [1] - Development costs are decreased by over 90% compared to traditional specialized models [1] Industry Recognition and Collaboration - The model has won the Sullivan Global Medical Imaging Foundation's Innovation Award, indicating its significance in the field [1] - Deshi Bio has established strategic partnerships with Wutongshu, Inspur Group, and ZTE Corporation to promote the application of AI in medical imaging [1]